Correlation of Lymphocyte Count with Treatment Response to Tyrosine Kinase Inhibitors in Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase

被引：0
|
作者：
Sasaki, Koji [1 ]
Rodriguez-Rivera, Ildefonso Ismael [2 ]
Kantarjian, Hagop M. [1 ]
O'Brien, Susan [1 ]
Jabbour, Elias [1 ]
Borthakur, Gautam [1 ]
Ravandi, Farhad [1 ]
Burke, Michael J. [3 ]
Zweidler-McKay, Patrick A. [1 ]
Cortes, Jorge E. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Univ Texas Southwestern, Austin, TX USA
[3] Med Coll Wisconsin, Milwaukee, WI 53226 USA
来源：
BLOOD | 2014年 / 124卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Class effects of tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia
    F J Giles
    M O'Dwyer
    R Swords
    Leukemia, 2009, 23 : 1698 - 1707
  • [32] Impact of Molecular Response at Specific Timepoints in Patients with Newly Diagnosed Chronic Myeloid Leukemia Treated with Second Generation Tyrosine Kinase Inhibitors
    Sasaki, Koji
    Kantarjian, Hagop M.
    Issa, Ghayas C.
    Garcia-Manero, Guillermo
    Kadia, Tapan M.
    Wierda, William G.
    Yilmaz, Musa
    DiNardo, Courtney D.
    Skinner, Jeffrey
    Khouri, Rita
    Pemmaraju, Naveen
    Nasnas, Patrice
    Dellasala, Sara E.
    Pierce, Sherry A.
    Cortes, Jorge E.
    Jabbour, Elias
    BLOOD, 2020, 136
  • [33] First-Line Second Generation Tyrosine Kinase Inhibitors in Newly Diagnosed Accelerated Phase Chronic Myeloid Leukemia Patients.
    Balsat, Marie
    Alcazer, Vincent
    Etienne, Gabriel
    Fossard, Gaelle
    Huguet, Francoise
    Berger, Marc G.
    Cayssials, Emilie
    Charbonnier, Aude
    Escoffre-Barbe, Martine
    Johnson-Ansah, Hyacinthe
    Dubruille, Viviane
    Legros, Laurence
    Roy, Lydia
    Delmer, Alain Jacques
    Ianotto, Jean-Christophe
    Gardembas, Martine
    Larosa, Fabrice
    Courby, Stephane
    Ame, Shanti
    Morisset, Stephane
    Mahon, Francois-Xavier
    Rea, Delphine
    Nicolini, Franck Emmanuel
    BLOOD, 2018, 132
  • [34] Preliminary Exploration of Patient Perspectives on Tyrosine Kinase Inhibitors for the Treatment of Chronic-Phase Chronic Myeloid Leukemia
    Mason, Bradley
    Mamolo, Carla M.
    Johnson, Chloe
    Viqueira, Andrea
    Gater, Adam
    Russell-Smith, Alexander
    Tatlock, Sophi
    Shah, Richa
    Cappelleri, Joseph C.
    BLOOD, 2019, 134
  • [35] Genetics and tyrosine kinase inhibitors of chronic myeloid leukemia
    Ganguly, Bani Bandana
    Kadam, Nitin N.
    NUCLEUS-INDIA, 2019, 62 (02): : 155 - 164
  • [36] Dual tyrosine kinase inhibitors in chronic myeloid leukemia
    Martinelli, G
    Soverini, S
    Rosti, G
    Baccarani, M
    LEUKEMIA, 2005, 19 (11) : 1872 - 1879
  • [37] Genetics and tyrosine kinase inhibitors of chronic myeloid leukemia
    Bani Bandana Ganguly
    Nitin N. Kadam
    The Nucleus, 2019, 62 : 155 - 164
  • [38] Resistance to tyrosine kinase inhibitors in chronic myeloid leukemia
    Lion, T.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S3 - S3
  • [39] New tyrosine kinase inhibitors in chronic myeloid leukemia
    Martinelli, Giovanni
    Soverini, Simona
    Rosti, Gianantonio
    Cilloni, Daniela
    Baccarani, Michele
    HAEMATOLOGICA, 2005, 90 (04) : 534 - 541
  • [40] Dual tyrosine kinase inhibitors in chronic myeloid leukemia
    G Martinelli
    S Soverini
    G Rosti
    M Baccarani
    Leukemia, 2005, 19 : 1872 - 1879
12345